Goodbye nip and tuck… hello to innovating enhancements

Research from the British Association of Aesthetic Plastic Surgeons (BAAPS) suggests cosmetic surgical procedures are continuing to decline (a fall of 7.9% from 2016), now that there are so many less invasive enhancement options to explore.1

Non-surgical cosmetic enhancements such as facial aesthetics including toxin and facial fillers can achieve the desired result without the need to go ‘under-the-knife’.

People are wanting to look refreshed and less tired whilst not changing the way they look completely. In research conducted by Galderma UK, when asked what motivated them to opt for non-surgical facial aesthetic treatment people stated, ‘to make myself look good as I get older’ with options that ensure ‘that the outcome looks natural’.2 The range of technologies now available when it comes to facial fillers — can enable clinicians to truly tailor a treatment to that individual’s aspirations for their skin.

Whether you are looking to contour and enhance your facial features or to address the visible signs of ageing and acne scars, by offering the broadest range of facial fillers, Restylane creates a flexible treatment approach.

Restylane uses a synthetic version of a naturally occurring substance from the body, hyaluronic acid (HA), which provides hydration and structure,

1. British Association of Aesthetic Plastic Surgeons. Annual Audit Results, 2018. Available at Accessed February 2018. 2. RARE research, 2017. 3. Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging. 2008;3(1):153-9. 4. Galderma, Data on file.

but is depleted as we age and is also quickly removed from the body.3 The Restylane range uses two types of HA technology;

• Non-Animal Stabilised HA (NASHA)TM technology — which creates a firmer gel for a more pronounced lift

• Optimal Balance Technology (OBT)TM —

which creates a softer gel that distributes more evenly to create a more natural look

To create these different technologies, Restylane gel is ‘cross-linked’ — an industry term meaning it has been intensified through a chemical process so that it stays in the skin, holding on to moisture for months before it’s broken down. The different gel textures are achieved by varying the number of ‘cross-links’ between HA molecules; fewer cross-links between HA molecules give rise to a softer gel, whereas more cross-links between HA molecules result in a firmer gel.

In the late 1980s, scientists wanted to find a way to restore skin moisture and structure by creating a product that could deliver naturally occurring HA into the skin. It had to be safe — closely resembling natural HA so that it would not be detected by the body as a foreign substance and cause an immune reaction – and offer long-lasting results.4 The resultant product was Restylane, the world’s first stabilised non- animal HA filler.

5. Rzany B et al. Full-face rejuvenation using a range of hyaluronic acid fillers: efficacy, safety, and patient satisfaction over 6 months. Dermatol Surg. 2012;38(7 Pt 2):1153-61. 6. Cartier H et al. Perioral rejuvenation with a wide range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips. J Drugs Dermatol. 2012;11:S17–S26.

And the innovation didn’t stop there. Since the first product was launched in 1996, Galderma have worked to create a range of products with carefully designed properties to suit patients’ individual needs. This has included creating products with diverse textures to offer different levels of lift or volume, and products specifically formulated to deliver skin hydration, all backed up with decades of clinical experience demonstrating safety and long-lasting results.5,6,7

Those interested in non-surgical aesthetic treatments such as fillers, should seek advice from a certified aesthetician.


preserves the natural way that HA molecules connect with each other.

7. Narins RS et al. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg. 2008;34(Suppl 1):S2-8.

RES18-02-0132 Date of Prep: Feb 2018

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56